Category: Vaccines
Europe Vaccines
-
Italy Vaccines Market Overview, 2028
... diseases. Their necessity cannot be overstated, as they play a crucial role in protecting individuals and communities from potentially life-threatening illnesses. Vaccines work by stimulating the immune system to produce antibodies against specific pathogens, such ... Read More
-
Europe Vaccines Market Outlook, 2028
... Vaccines provide direct benefits by preventing infections, hospitalizations, medical complications and their related treatment costs and also indirect benefits such as minimizing the impact of vaccine-preventable diseases on family or improving labor productivity. Today, close ... Read More
-
Germany Vaccines Market Overview, 2028
... the prevention and control of infectious disease outbreaks. They underpin global health security and will be a vital tool in the battle against antimicrobial resistance. Historically, Germany has had high vaccine coverage rates for diseases ... Read More
-
United Kingdom (UK) Vaccines Market Overview, 2028
... at the next encounter. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for granting authorization (license) for use, based on an assessment of: vaccine safety and efficacy using the data ... Read More
-
Spain Vaccines Market Overview, 2028
... research and development, vaccine production, and vaccination campaigns, with various government associations and organizations playing key roles. The Spanish government is instrumental in promoting vaccine development and usage. The Ministry of Health, Consumer Affairs, and ... Read More
-
France Vaccines Market Overview, 2028
... reducing illness, disability, and mortality caused by a wide range of pathogens. Vaccines work by stimulating the immune system to recognize and combat specific viruses or bacteria, creating immunity without causing the disease itself. This ... Read More
-
Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Administration (Subcutaneous, Intramuscular, Intranasal); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029
... By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029 Europe Veterinary Vaccine Market Size Set to Reach USD 4.5 Billion by 2029 Europe veterinary vaccine ... Read More
-
Mediterranean Fish Vaccine Market Forecast to 2030 - Regional Analysis by Vaccine Type (Inactivated Vaccine, Live-attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccine), Route of Administration (Immersion Vaccine, Injection Vaccine, and Oral Vaccine), Species (Turbot, European Anchovy and Seabass, Salmon, Mediterranean Sea Bass, Common Dentex and Common Pandora, Sea Bream, Rainbow Wrasse, Sparus Aurata, Trout, Mediterranean Swordfish and Bluefin Tuna, Grouper and Amberjack, and Others), and Country
... Oral Vaccine), Species (Turbot, European Anchovy and Seabass, Salmon, Mediterranean Sea Bass, Common Dentex and Common Pandora, Sea Bream, Rainbow Wrasse, Sparus Aurata, Trout, Mediterranean Swordfish and Bluefin Tuna, Grouper and Amberjack, and Others), and ... Read More
-
Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical ... Read More
-
Biopharmaceutical Excipient Manufacturing Market by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers / Surfactants, Polyols, Proteins / Amino Acids and Others, Company Size (Small, Mid-sized, Large / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035
... / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035 Over the years, the rising popularity ... Read More
-
Europe Vaccine Packaging Market - Focused Insights 2023-2028
... products are included in the report. Revenue generated by service providers are excluded from the scope of the report. This report provides a comprehensive and current market scenario of Europe vaccine packaging, including the market ... Read More
-
Companion Animal Pharmaceuticals Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Animal (Dogs, Cats, Horses); By Route of Administration (Oral, Injectable, Topical); By Product (Antibiotics, Anti-Inflammatory, Parasiticides, Vaccines); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Global Companion Animal Pharmaceuticals Market Size Set to Touch USD 45.12 Billion by 2029 Global companion animal pharmaceuticals market is flourishing because of ... Read More
-
Cell Culture Consumables and Equipment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Consumables, Instruments); By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening & Development, Recombinant Products, Stem Cell Technology, Regenerative Medicine); By End User (Industrial, Biotechnology, Agriculture); By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)
... Stem Cell Technology, Regenerative Medicine); By End User (Industrial, Biotechnology, Agriculture); By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa) Global Cell Culture Consumables and Equipment Market Size More Than ... Read More
-
Veterinary Medicine Market, By Animal Type (Domesticated and Companion), By Product (Drug and Vaccines), By Route of Administration (Oral, Parental, and Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Stores, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Veterinary medicine is a branch of medicine that deals with prevention, management, ... Read More
-
Microneedle Flu Vaccine Market, By Product Type (Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle), By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), By Flu Type (Influenza A( H1N1, H3N1), Influenza B), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Drug delivery through the skin using transdermal patches has always been effective against viral infections ... Read More
-
Pediatric Vaccines Market, By Vaccine Type (Pneumococcal Vaccine, DTP Vaccine, Rotavirus Vaccine, MMR Vaccine, Polio Vaccine, Influenza Vaccine, Hepatitis B Vaccine, Meningococcal Vaccine, Hib Vaccine, Varicella Vaccine), By Technology (Live or Attenuated Vaccine, Inactivated or Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, ... Read More
-
United Kingdom Veterinary Medicine Market, By Animal Type (Production v/s Companion), By Production (Poultry, Swine, Cattle, Others), By Companion (Dogs, Cats, Horses, Others), By Product Type (Vaccine, Pharmaceuticals, Medicated Feed Additives), By End User (Veterinary Hospitals & Clinics, Reference Laboratories, Others), By Source (Domestic v/s Import), By Region, Competition Forecast & Opportunities, 2027
... Hospitals & Clinics, Reference Laboratories, Others), By Source (Domestic v/s Import), By Region, Competition Forecast & Opportunities, 2027 The United Kingdom veterinary medicine market is anticipated to witness a robust CAGR in the forecast period, ... Read More
-
Europe Aquaculture Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Vaccine (Live Vaccine, Inactivated Vaccine, and Others), Species (Tilapia, Trout, Salmon, Shrimps, and Others), and Route of Administration (Injection Vaccines, Immersion Vaccines, and Oral Vaccines)
... (Injection Vaccines, Immersion Vaccines, and Oral Vaccines) The Europe aquaculture vaccines market is expected to grow from US$ 98.58 million in 2022 to US$ 202.54 million by 2028. It is estimated to grow at a ... Read More
-
m-RNA Synthesis Service Market, By Application (Therapeutic Development, Vaccine Production, Drug Discovery, Others), By Scale of Operation (Research, Commercial), By End User (Biopharmaceutical Companies, Contract research organizations (CROs), Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information ... Read More
-
Europe Monkeypox Testing Market - Industry Outlook and Forecast 2023-2025
... INSIGHTS Syndromic tests for monkeypox detection are expected to witness strong growth because they can distinguish monkeypox from other harmful diseases, allowing for easier treatment. On 25th May 2022, Roche and its subsidiary TIB Molbiol ... Read More
-
Poultry Vaccine Market, By Disease (Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Other Diseases), By Technology (Live Attenuated Vaccines (LAV), Recombinant Vaccines, Inactivated Vaccines, and Other Technologies), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Vaccines help to prevent any particular disease by boosting the bird’s immune system to produce antibodies, which in turn, ... Read More
-
Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Other Products), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Biologics are medicines developed from blood, proteins, viruses, or living organisms, and are used to prevent, treat, and cure many health ... Read More
-
Plasmid DNA Manufacturing Market, By Product Type (Viral Vectors, Plasmid DNA and Non-viral Vectors), By Grade (GMP Grade, R&D Grade and Clinical Grade), By Application (DNA Vaccines, Gene Therapy, Immunotherapy, RNA Vaccines and Others), By Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Manufacturing Type (Outsourcing and In-house Manufacturing), By Development Phase (Pre-Clinical Therapeutics, Clinical Therapeutics and Marketed Therapeutics), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult & Pediatric), By Composition (Mono & Combination), By Region (The US, China, EU+UK, Japan & ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 The global hepatitis B virus (HBV) vaccine market was valued at US$2.23 billion in 2021, and is predicted to grow to US$3.04 billion in 2027. The hepatitis B virus (HBV) ... Read More
-
Diphtheria Vaccine Market, by Vaccine Type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), by Age Group (Pediatrics and Adults), by End User (Hospitals, Clinics, and Vaccination Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diphtheria is a serious infection caused by strains of bacteria called Corynebacterium diphtheriae that make a toxin. It ... Read More
Research Assistance
